Cargando…

CD34(+) progenitor cells as diagnostic and therapeutic targets in Alzheimer’s disease

Detalles Bibliográficos
Autores principales:	Romaus-Sanjurjo, Daniel, Custodia, Antía, Ouro, Alberto, Sobrino, Tomás
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Wolters Kluwer - Medknow 2022
Materias:	Perspective
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9727436/ https://www.ncbi.nlm.nih.gov/pubmed/36018165 http://dx.doi.org/10.4103/1673-5374.346485

Ejemplares similares

Endothelial Progenitor Cells and Vascular Alterations in Alzheimer’s Disease
por: Custodia, Antía, et al.
Publicado: (2022)

Unraveling the potential of endothelial progenitor cells as a treatment following ischemic stroke
por: Custodia, Antía, et al.
Publicado: (2022)

Ceramide/Sphingosine 1-Phosphate Axis as a Key Target for Diagnosis and Treatment in Alzheimer’s Disease and Other Neurodegenerative Diseases
por: Custodia, Antía, et al.
Publicado: (2022)

Biomarkers Assessing Endothelial Dysfunction in Alzheimer’s Disease
por: Custodia, Antía, et al.
Publicado: (2023)

Stress Granules and Acute Ischemic Stroke: Beyond mRNA Translation
por: Aramburu-Núñez, Marta, et al.
Publicado: (2022)

Alzheimer’s Disease Seen through the Eye: Ocular Alterations and Neurodegeneration
por: Romaus-Sanjurjo, Daniel, et al.
Publicado: (2022)

Periodontal inflammation is associated with increased circulating levels of endothelial progenitor cells: a retrospective cohort study in a high vascular risk population
por: Vázquez-Reza, María, et al.
Publicado: (2023)

Ceramide Metabolism and Parkinson’s Disease—Therapeutic Targets
por: Custodia, Antía, et al.
Publicado: (2021)

Ceramide Metabolism Enzymes—Therapeutic Targets against Cancer
por: Gomez-Larrauri, Ana, et al.
Publicado: (2021)

Involvement of Ceramide Metabolism in Cerebral Ischemia
por: Ouro, Alberto, et al.
Publicado: (2022)

Gamma-aminobutyric acid (GABA) promotes recovery from spinal cord injury in lampreys: role of GABA receptors and perspective on the translation to mammals
por: Romaus-Sanjurjo, Daniel, et al.
Publicado: (2019)

Editorial: New challenges and future perspectives in neurodegeneration
por: Li, Zhenyu, et al.
Publicado: (2022)

Adipocytokines and CD34(+) Progenitor Cells in Alzheimer's Disease
por: Bigalke, Boris, et al.
Publicado: (2011)

Diagnostic and therapeutic potential of exosomal miRNAs in Alzheimer’s disease
por: Manna, Ida, et al.
Publicado: (2021)

TREM2 as an evolving therapeutic target in Alzheimer’s disease
por: George, Jacob
Publicado: (2023)

Caveolae, CD109, and endothelial cells as targets for treating Alzheimer's disease
por: Fessel, Jeffrey
Publicado: (2020)

Heparan sulfate proteoglycans as possible diagnostic molecular tools with therapeutic potential in Alzheimer´s disease
por: Fernández-Vega, Iván, et al.
Publicado: (2020)

Neurovascular ageing: transcriptomic readout and implications on therapeutic targeting in Alzheimer's disease
por: Li, Zhongqi, et al.
Publicado: (2021)

Is EAAT2 a potential therapeutic intervention target for Alzheimer’s disease?
por: Wood, Oliver WG, et al.
Publicado: (2023)

Targeting calcium signaling in Alzheimer’s disease: challenges and promising therapeutic avenues
por: Song, LinLin, et al.
Publicado: (2023)

Heparan sulfate proteoglycans and heparanases in Alzheimer's disease: current outlook and potential therapeutic targets
por: Lorente-Gea, Laura, et al.
Publicado: (2017)

Vascular dysfunction in Alzheimer’s disease: a biomarker of disease progression and a potential therapeutic target
por: Govindpani, Karan, et al.
Publicado: (2019)

Next generation therapeutics for Alzheimer's disease
por: Bredesen, Dale E, et al.
Publicado: (2013)

Emerging small-molecule therapeutic approaches for Alzheimer's disease and Parkinson's disease based on targeting microRNAs
por: Abdelrahman, Somaya A., et al.
Publicado: (2021)

Phenotyping and Target Expression Profiling of CD34(+)/CD38(−) and CD34(+)/CD38(+) Stem- and Progenitor cells in Acute Lymphoblastic Leukemia
por: Blatt, Katharina, et al.
Publicado: (2018)

Active immunotherapy and alternative therapeutic modalities for Alzheimer's disease
por: Weninger, Stacie, et al.
Publicado: (2020)

Cannabinoid pharmacology and its therapeutic uses in Alzheimer’s disease
por: Monteiro, Kadja Luana Chagas, et al.
Publicado: (2020)

New unexpected role for Wolfram Syndrome protein WFS1: a novel therapeutic target for Alzheimer’s disease?
por: Chen, Shuo, et al.
Publicado: (2022)

Diagnostic dilemmas in Alzheimer's disease: Room for shared decision making
por: van der Flier, Wiesje M., et al.
Publicado: (2017)

Targeting abnormal metabolism in Alzheimer's disease: The Drug Repurposing for Effective Alzheimer's Medicines (DREAM) study
por: Desai, Rishi J., et al.
Publicado: (2020)

Therapeutic gene editing in CD34(+) hematopoietic progenitors from Fanconi anemia patients
por: Diez, Begoña, et al.
Publicado: (2017)

On the horizon—the value and promise of the global pipeline of Alzheimer's disease therapeutics
por: Cole, Michael A., et al.
Publicado: (2020)

Estrogens still represent an attractive therapeutic approach for Alzheimer’s disease
por: Tamagno, Elena, et al.
Publicado: (2021)

Potential contributions of trace amines in Alzheimer’s disease and therapeutic prospects
por: Dhakal, Sudip, et al.
Publicado: (2020)

The new K(V)3.4 inhibitor BDS-I[1–8] as a potential pharmacological opportunity in Alzheimer’s disease therapy
por: Piccialli, Ilaria, et al.
Publicado: (2020)

Endothelial progenitor cells as a therapeutic option in intracerebral hemorrhage
por: Pías-Peleteiro, Juan, et al.
Publicado: (2017)

Chromatin Complexes Maintain Self-Renewal of Myeloid Progenitors in AML: Opportunities for Therapeutic Intervention
por: Uckelmann, Hannah J., et al.
Publicado: (2020)

The therapeutic potential of mesenchymal stem cells in Alzheimer's disease: converging mechanisms
por: Turgeman, Gadi
Publicado: (2015)

Using Plants as a Source of Potential Therapeutics for the Treatment of Alzheimer’s Disease
por: Maher, Pamela A.
Publicado: (2020)

Repurposing ibrutinib: therapeutic effects and implications for translational approaches in Alzheimer’s disease
por: Lee, Hyun-ju, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_mh8ur8judm5qsonqeapamdbl9c